IV Tubing Sets and Accessories Market Size, Share, Growth, and Industry Analysis, By Type (Peripheral Intravenous Catheter Insertion, Central Venous Catheter Placement, PICC Line Insertion), By Application (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Skilled Nursing Facilities, Long Term Care Centers, Others), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

IV TUBING SETS AND ACCESSORIES MARKET OVERVIEW

The global IV Tubing Sets and Accessories Market size estimated at USD 3.23 billion in 2026 and is projected to reach USD 4.33 billion by 2035, growing at a CAGR of 3.32% from 2026 to 2035.

The IV Tubing Sets and Accessories Market is expanding through increasing use of intravenous therapy for hydration, medication delivery, chemotherapy, antibiotics, nutrition, anesthesia, and critical-care treatment. North America accounted for approximately 46.9% of global market activity in 2024, supported by advanced hospital infrastructure and extensive infusion-pump deployment. Primary IV tubing sets represented approximately 29.4% of product demand in 2024. Hospitals remain the largest end-user category because emergency departments, intensive care units, operating rooms, oncology wards, and general inpatient departments consume disposable IV administration sets continuously. Safety-engineered connectors, DEHP-free tubing, needle-free access systems, and closed infusion configurations are increasingly influencing procurement decisions.

The United States represents the largest individual country market, supported by more than 6,000 hospitals, approximately 33 million annual hospital admissions, and extensive use of intravenous medications in emergency, surgical, oncology, and intensive-care settings. In 2024, disruption at a major North Carolina IV manufacturing facility affected a plant responsible for approximately 60% of the country's IV fluids and selected dialysis solutions, demonstrating supply-chain dependence on concentrated production capacity. The facility normally produced approximately 1.5 million bags daily. During the shortage response, another manufacturer announced a 20% increase in saline production and additional annual IV-set output exceeding 30 million units.

KEY FINDINGS

LATEST TRENDS

The IV Tubing Sets and Accessories Market is increasingly influenced by smart infusion compatibility, needle-free technology, closed-system designs, non-DEHP materials, and improved flow-control mechanisms. In 2024, North America represented approximately 46.9% of global market activity, reflecting strong adoption of advanced infusion technologies. Primary IV tubing sets accounted for approximately 29.4% of product demand, supported by widespread applications in hydration, antibiotics, analgesics, chemotherapy, blood products, and critical-care medication delivery.

A major trend involves migration toward safer materials and configurations. Hospitals increasingly evaluate tubing for 5 major characteristics: drug compatibility, pump integration, pressure resistance, air-elimination capability, and infection prevention. Needle-free connectors reduce occupational exposure associated with sharps, while closed systems help limit contamination risk during repeated vascular access. Supply resilience has also become a strategic market trend. During 2024, flooding disrupted a U.S. facility responsible for approximately 60% of national IV-fluid and selected dialysis-solution supply.

MARKET DYNAMICS

Driver

Rising hospital admissions and increasing intravenous therapy utilization.

The principal driver of the IV Tubing Sets and Accessories Market is the increasing frequency of intravenous treatment across emergency medicine, oncology, surgery, intensive care, infectious-disease management, hydration therapy, and parenteral nutrition. The United States records approximately 33 million hospital admissions annually, creating sustained consumption of disposable tubing, extension sets, connectors, filters, stopcocks, and accessories. North America accounted for approximately 46.9% of market activity in 2024, demonstrating the relationship between advanced healthcare infrastructure and IV-consumable usage.

Restraint

Supply-chain concentration and growing pressure to control disposable medical waste.

The IV Tubing Sets and Accessories Market faces significant restraints from manufacturing concentration, raw-material dependency, product recalls, sterilization requirements, and environmental concerns surrounding single-use plastics. The 2024 disruption of a major North Carolina manufacturing plant demonstrated the consequences of concentrated production, as the facility supplied approximately 60% of U.S. IV fluids and selected dialysis solutions and normally produced approximately 1.5 million bags daily. Hospitals subsequently implemented conservation strategies and delayed selected procedures.

Expansion of home infusion, ambulatory care, and advanced safety-engineered tubing systems

Opportunity

Home infusion and outpatient therapy create major opportunities for IV tubing manufacturers because healthcare delivery is increasingly extending beyond traditional inpatient settings. Ambulatory surgical centers, specialized clinics, skilled nursing facilities, and long-term care centers collectively represent a growing portion of IV consumable utilization.

Manufacturers can address this opportunity through compact tubing configurations, anti-free-flow protection, needle-free connectors, integrated filters, and simplified priming systems. Primary IV tubing sets already account for approximately 29.4% of product demand, demonstrating the importance of versatile administration products.

Maintaining medication accuracy, sterility, compatibility, and uninterrupted product availability

Challenge

Manufacturers face the challenge of ensuring that every tubing configuration maintains consistent flow, pressure tolerance, material compatibility, and sterility throughout its intended use. A hospital can operate hundreds of infusion pumps simultaneously, requiring tubing sets compatible with different medications, pumps, connectors, and clinical protocols.

During the 2024 U.S. supply disruption, hospitals were forced to conserve IV resources after a manufacturing facility supplying approximately 60% of domestic IV fluids and selected dialysis products ceased production temporarily. Such events demonstrate that product availability is as important as technical performance.

•   
•   
  

  Download Free Sample to learn more about this report

    

IV TUBING SETS AND ACCESSORIES MARKET SEGMENTATION

By Type

• Peripheral Intravenous Catheter Insertion: Peripheral intravenous catheter insertion holds an estimated 48% share of procedure-related IV tubing demand because peripheral access is the most common route for short-duration intravenous treatment. Hospitals use peripheral IV systems for hydration, antibiotics, pain medication, emergency therapy, contrast delivery, and perioperative care. A single hospital admission can involve more than 1 peripheral catheter placement when initial access fails or therapy continues for several days. The segment benefits from demand for extension tubing, needle-free connectors, primary sets, secondary sets, and flow-control accessories.

• Central Venous Catheter Placement: Central venous catheter placement represents approximately 31% of procedure-related market demand, supported by critical care, oncology, hemodynamic monitoring, parenteral nutrition, and administration of vesicant medications. Central venous access can support multiple lumens, enabling simultaneous delivery of 2, 3, or more therapies depending on catheter design. These procedures require specialized tubing configurations, needle-free connectors, extension lines, stopcocks, and filters. Demand is particularly concentrated in intensive-care units, cancer centers, transplant departments, and major surgical hospitals.

• PICC Line Insertion: PICC line insertion accounts for an estimated 21% share of procedure-related IV tubing demand and is widely used for extended antibiotic therapy, chemotherapy, nutritional support, and treatments lasting several weeks. PICCs provide central venous access through a peripheral insertion site and can be configured with 1, 2, or 3 lumens. The segment supports demand for extension sets, needle-free connectors, securement accessories, flushing components, and compatible infusion tubing. Home infusion expansion strengthens PICC-related consumption because patients can continue prescribed intravenous therapy outside acute-care hospitals.

By Application

• Hospitals: Hospitals account for approximately 55% of IV tubing sets and accessories demand, making them the dominant end-user category. More than 6,000 hospitals operate across the United States, while large facilities may maintain hundreds of inpatient beds and multiple intensive-care departments. IV tubing is consumed continuously in emergency rooms, operating theaters, oncology departments, pediatric wards, critical-care units, and general medical departments. Each active IV line may require primary tubing, extension sets, secondary tubing, filters, connectors, and stopcocks.

• Ambulatory Surgical Centers: Ambulatory surgical centers represent approximately 13% of end-user demand, supported by increasing outpatient procedures requiring anesthesia, sedation, hydration, antibiotics, and pain-management infusions. The United States has more than 6,000 Medicare-certified ambulatory surgical centers, demonstrating the substantial scale of outpatient surgical infrastructure. These facilities prioritize efficient turnover, compact infusion equipment, standardized tubing configurations, and products that reduce setup complexity.

• Specialized Clinics: Specialized clinics account for approximately 11% of IV tubing demand, driven by oncology, rheumatology, gastroenterology, immunology, infectious-disease, and specialty-infusion services. Many biological drugs require intravenous administration over 30 minutes or several hours, depending on therapy protocols. Oncology centers can operate dozens of infusion chairs daily, creating recurring consumption of primary tubing, secondary sets, filtered tubing, connectors, and extension devices. The segment increasingly adopts closed-system configurations and specialized filters for selected medications.

• Skilled Nursing Facilities: Skilled nursing facilities represent approximately 8% of IV tubing sets and accessories demand, particularly for antibiotics, hydration, pain management, and nutritional support. The United States has approximately 15,000 nursing homes, supporting a substantial patient base requiring post-acute and extended care. Residents may require intravenous antibiotics for several days, generating repeated demand for administration sets, extension tubing, and needle-free connectors. Facilities emphasize easy-to-use systems because staffing structures differ from major hospitals.

• Long Term Care Centers: Long-term care centers hold approximately 7% of end-user demand and use IV tubing systems for hydration, antimicrobial therapy, nutritional support, and palliative treatment. Elderly residents frequently present with multiple chronic conditions, and people aged 65 years and older represent an expanding demographic across North America, Europe, and East Asia. Long-duration treatment creates demand for reliable extension sets, needle-free connectors, and administration tubing that can be managed outside high-acuity hospital environments.

• Others: The others category represents approximately 6% of demand and includes home infusion providers, emergency medical services, dialysis centers, military healthcare facilities, and community-based infusion programs. Home infusion is particularly important because treatments involving antibiotics, hydration, parenteral nutrition, and selected specialty drugs can be delivered outside hospitals. Portable pumps and simplified tubing configurations support patient mobility and extended therapy. Emergency medical services also require IV administration products for fluid resuscitation and medication delivery during transport.

•   
•   
  Download Free Sample to learn more about this report

    

IV TUBING SETS AND ACCESSORIES MARKET REGIONAL INSIGHTS

• North America

North America dominates the IV Tubing Sets and Accessories Market with approximately 46.9% share, supported by advanced hospitals, high surgical volumes, extensive cancer treatment infrastructure, and widespread adoption of infusion pumps. The United States represents the region's principal market and operates more than 6,000 hospitals, creating recurring consumption of primary tubing, secondary sets, extension lines, filters, needle-free connectors, and accessories.

The region's supply-chain vulnerability became highly visible in 2024, when flooding affected a North Carolina manufacturing facility responsible for approximately 60% of U.S. IV fluids and selected peritoneal dialysis solutions. The facility normally produced approximately 1.5 million bags per day, and the disruption prompted hospitals to conserve IV resources and delay selected elective procedures.

• Europe

Europe accounts for an estimated 25% share of the IV Tubing Sets and Accessories Market, supported by universal healthcare systems, established hospital infrastructure, strict infection-control requirements, and large aging populations. Germany, France, the United Kingdom, Italy, and Spain represent major demand centers, while Germany maintains more than 1,800 hospitals and has strong domestic medical-device manufacturing capabilities.

European hospitals increasingly prioritize closed infusion systems, needle-free connectors, PVC alternatives, DEHP-free components, and products designed to reduce occupational exposure. The region's population exceeds 740 million people, creating a substantial healthcare base for surgery, cancer therapy, critical care, antimicrobial treatment, and chronic-disease management.

• Asia-Pacific

Asia-Pacific represents approximately 22% of the IV Tubing Sets and Accessories Market and offers substantial expansion potential due to population scale, hospital construction, increasing insurance coverage, and greater treatment access. China and India each have populations exceeding 1.4 billion, while Japan has one of the world's oldest demographic structures, with approximately 29% of residents aged 65 years or older.

China leads regional demand through extensive tertiary-hospital infrastructure, expanding critical-care capacity, and rising domestic production of disposable medical devices. India operates a rapidly developing private hospital sector, while government healthcare programs are expanding treatment access among hundreds of millions of residents.

• Middle East & Africa

The Middle East & Africa region accounts for approximately 6% of the IV Tubing Sets and Accessories Market, with demand concentrated in Saudi Arabia, the United Arab Emirates, South Africa, Egypt, and other countries investing in healthcare modernization. Saudi Arabia has a population exceeding 34 million, while South Africa has more than 60 million residents, creating substantial requirements for hospital consumables.

Gulf countries are investing in advanced hospitals, oncology facilities, surgical centers, and specialty clinics. Large tertiary hospitals can operate more than 500 beds, requiring continuous supplies of primary IV sets, secondary tubing, connectors, extension lines, and flow-control devices. In Africa, infectious diseases, emergency treatment, maternal healthcare, and hospital expansion support baseline demand for reliable intravenous administration products.

LIST OF TOP IV TUBING SETS AND ACCESSORIES COMPANIES

• Poly Medicure
• B Braun Melsungen
• Health Line International Corporation
• Zyno Medical
• R. Bard
• ICU Medical
• Baxter International
• Dynarex
• Smiths Medical
• Nipro
• Vygon U.S.A
• Fresenius Kabi
• Perfect Medical
• Becton Dickinson and Company (CareFusion)
• Hospira (Pfizer)

List Of Top 2 Companies Market Share

• B Braun Melsungen: Estimated to account for approximately 15% of competitive IV tubing and administration-set supply across major markets, supported by extensive infusion-therapy manufacturing, hospital relationships, and a 2024 initiative adding more than 30 million IV sets to annual U.S. output capacity.
• Baxter International: Estimated to account for approximately 14% of the competitive market, supported by a large intravenous therapy portfolio and extensive hospital presence. Its North Carolina facility was associated with approximately 60% of U.S. IV fluids and selected dialysis-solution supply before the 2024 disruption.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment activity in the IV Tubing Sets and Accessories Market increasingly targets manufacturing resilience, automation, smart-infusion compatibility, alternative materials, and geographic diversification. The 2024 U.S. supply disruption demonstrated the importance of redundant production because a single North Carolina facility was associated with approximately 60% of national IV fluids and selected dialysis solutions. In response to broader shortages, B Braun announced a 20% saline-production increase and additional annual IV-set capacity exceeding 30 million units.

Manufacturers have opportunities to invest in automated extrusion, assembly, packaging, sterilization, and inspection systems. Machine-vision platforms can evaluate 100% of production output for selected defects when integrated into automated lines. Investment in non-DEHP materials is another opportunity because hospitals increasingly assess plasticizer exposure and environmental performance. Emerging economies also offer significant potential. China and India each have populations exceeding 1.4 billion, creating sustained demand for affordable sterile infusion products.

NEW PRODUCT DEVELOPMENT

New product development in the IV Tubing Sets and Accessories Market focuses on 5 primary priorities: patient safety, medication accuracy, infection prevention, environmental improvement, and workflow efficiency. Manufacturers are developing tubing systems with needle-free connectors, integrated filters, anti-free-flow mechanisms, air-elimination features, and enhanced pump compatibility. Material innovation is particularly significant. DEHP-free and PVC-alternative tubing products address growing concerns regarding chemical exposure and medical plastic waste.

Manufacturers are also optimizing internal tubing diameter and reducing residual volume, which can be particularly important for expensive biologics, neonatal medications, and high-potency drugs where even 1 mL of retained medication can influence dose delivery or product wastage. Smart-infusion integration is another development priority. Modern administration sets must function reliably with pumps incorporating dose-error reduction software and extensive medication libraries. Product developers are improving connector designs to minimize accidental disconnection and developing closed configurations that reduce repeated manipulation.

FIVE RECENT DEVELOPMENTS (2023-2025)

• March 2023: Becton Dickinson and Company introduced a new initiative related to the IV Tubing Sets and Accessories Market market. The company advanced its vascular-access and infusion-therapy portfolio with safety-focused technologies supporting peripheral and central intravenous procedures. The initiative emphasized needle-free connectivity, catheter stabilization, and standardized medication-delivery workflows, strengthening demand for compatible IV extension sets, connectors, administration tubing, and accessories across hospitals and specialized infusion centers.
• October 2023: ICU Medical developed a new initiative related to the IV Tubing Sets and Accessories Market market. The company strengthened its integrated infusion-therapy portfolio by advancing closed-system connectors, administration sets, and pump-compatible tubing technologies. The development focused on reducing medication exposure, improving connection security, and supporting accurate drug delivery across intensive-care, oncology, surgical, and general hospital environments.
• August 2024: Fresenius Kabi expanded a new initiative related to the IV Tubing Sets and Accessories Market market. The company accelerated infusion-solution production activities as healthcare systems experienced supply constraints and increasing intravenous therapy requirements. The initiative supported broader availability of infusion products used with administration sets, connectors, valves, and tubing accessories, strengthening supply continuity across hospitals and critical-care facilities.
• October 2024: B. Braun Medical announced a new initiative related to the IV Tubing Sets and Accessories Market market. The company increased IV saline production by 20% at facilities in California and Florida and expanded annual IV-set production capacity by more than 30 million units. B. Braun also increased output of infusion valves and connectors, strengthening domestic supply resilience and hospital product availability.
• January 2025: Baxter International expanded a new initiative related to the IV Tubing Sets and Accessories Market market. The company continued restoring intravenous-product manufacturing capacity at its North Carolina facility following the 2024 hurricane disruption that affected a site producing approximately 60% of U.S. IV fluids and selected dialysis solutions. The recovery initiative strengthened supply continuity, manufacturing resilience, and hospital access to critical infusion products.

IV TUBING SETS AND ACCESSORIES MARKET REPORT COVERAGE

The IV Tubing Sets and Accessories Market report covers product utilization across 3 major procedure categories: peripheral intravenous catheter insertion, central venous catheter placement, and PICC line insertion. End-user analysis evaluates 6 categories comprising hospitals, ambulatory surgical centers, specialized clinics, skilled nursing facilities, long-term care centers, and other healthcare settings. The report evaluates 4 major geographic regions: North America, Europe, Asia-Pacific, and Middle East & Africa. North America represented approximately 46.9% of global activity in 2024, while primary IV tubing sets accounted for approximately 29.4% of product demand.

Competitive coverage includes 15 named companies operating across infusion therapy, vascular access, disposable medical products, and associated accessories. The IV Tubing Sets and Accessories Market Report examines drivers including rising hospital admissions, increasing chronic-disease treatment, surgical activity, oncology infusion, critical-care utilization, and home infusion. It also evaluates restraints involving supply concentration, single-use plastic waste, manufacturing complexity, sterilization requirements, and regulatory compliance.